6-Bromo-2-(4-fluorophenyl)imidazo[1,2-a]pyridine, 97%, 2g

9-n-Octyl-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole>97.0%(HPLC)(N)200mg

4-Bromo-2-methyl-5-nitroaniline, 95.0%, 25g

4-methyl-2-thien-2-yl-1,3-thiazole-5-carboxylic acid, 95.0%, 1g

Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-6-carboxylate, 95.0%, 100mg

(E)-1-(5-Methoxy-2,2-dimethyl-2H-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one, 97.0%, 100mg

4-Aminocyclohexanecarbonitrile hydrochloride, 95.0%, 1g

9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid, 95.0%, 1g

8-(Tosylamino)quinoline, 98%, 25g

Substance P, 95.0%, 1mg

ethyl 1-(4-fluorophenyl)-4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate, 95.0%, 500mg

2-{[6-Chloro-4-(trifluoromethyl)pyridin-2-yl]thio}acetohydrazide, 95.0%, 1g

3-(Bromomethyl)benzaldehyde, 97.0%, 1g